The approval of lengthy-acting cabotegravir injected once each and every two months expands biomedical HIV avoidance alternatives accessible to people in the United States, supplying an alternative to day by day oral tablets. Add and/or solicit Guest Edited thematic troubles on the journal inside of a very hot space (not https://www.directivepublications.org/journal-of-hiv-aids-research/